Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibiotic Prophylaxis | 2 | 2022 | 38 | 1.360 |
Why?
|
| Cesarean Section | 3 | 2021 | 55 | 1.280 |
Why?
|
| Uterine Contraction | 5 | 2016 | 6 | 0.910 |
Why?
|
| Azithromycin | 2 | 2022 | 11 | 0.870 |
Why?
|
| Pregnancy | 15 | 2022 | 1261 | 0.830 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 4 | 2012 | 7 | 0.770 |
Why?
|
| Puerperal Infection | 1 | 2022 | 4 | 0.740 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 131 | 0.690 |
Why?
|
| Pregnancy Complications | 2 | 2020 | 112 | 0.680 |
Why?
|
| Preoperative Care | 1 | 2021 | 81 | 0.660 |
Why?
|
| Labor, Induced | 1 | 2020 | 19 | 0.610 |
Why?
|
| Health Policy | 1 | 2020 | 63 | 0.590 |
Why?
|
| Methamphetamine | 1 | 2019 | 21 | 0.570 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2019 | 19 | 0.570 |
Why?
|
| Myometrium | 4 | 2011 | 7 | 0.560 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 34 | 0.560 |
Why?
|
| Obesity | 3 | 2022 | 705 | 0.540 |
Why?
|
| Pregnancy, Animal | 2 | 2015 | 12 | 0.440 |
Why?
|
| Telemetry | 2 | 2015 | 8 | 0.430 |
Why?
|
| Uterus | 4 | 2017 | 31 | 0.380 |
Why?
|
| Female | 17 | 2022 | 15826 | 0.370 |
Why?
|
| Sp3 Transcription Factor | 1 | 2010 | 1 | 0.330 |
Why?
|
| Sp1 Transcription Factor | 1 | 2010 | 17 | 0.320 |
Why?
|
| Parturition | 1 | 2010 | 17 | 0.310 |
Why?
|
| Cohort Studies | 3 | 2021 | 903 | 0.310 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 646 | 0.280 |
Why?
|
| Adrenomedullin | 2 | 2018 | 10 | 0.270 |
Why?
|
| Obstetric Labor, Premature | 1 | 2008 | 15 | 0.270 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 540 | 0.260 |
Why?
|
| Adult | 4 | 2021 | 8131 | 0.210 |
Why?
|
| Models, Animal | 2 | 2018 | 130 | 0.210 |
Why?
|
| Humans | 11 | 2022 | 29214 | 0.200 |
Why?
|
| Mice | 9 | 2018 | 4870 | 0.200 |
Why?
|
| Infant, Newborn | 2 | 2022 | 932 | 0.180 |
Why?
|
| Endometritis | 1 | 2021 | 2 | 0.170 |
Why?
|
| Controlled Before-After Studies | 1 | 2021 | 4 | 0.170 |
Why?
|
| Cefazolin | 1 | 2021 | 6 | 0.170 |
Why?
|
| Holoprosencephaly | 1 | 2021 | 3 | 0.170 |
Why?
|
| Septo-Optic Dysplasia | 1 | 2021 | 3 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 6 | 2016 | 1684 | 0.170 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 210 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2022 | 467 | 0.160 |
Why?
|
| Surgical Wound Infection | 1 | 2021 | 108 | 0.160 |
Why?
|
| Gene Expression | 3 | 2016 | 418 | 0.160 |
Why?
|
| Malpractice | 1 | 2020 | 8 | 0.160 |
Why?
|
| Animals | 10 | 2018 | 10806 | 0.160 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 49 | 0.150 |
Why?
|
| Protein Precursors | 1 | 2018 | 11 | 0.140 |
Why?
|
| Prenatal Care | 1 | 2019 | 47 | 0.140 |
Why?
|
| Sequence Deletion | 1 | 2018 | 66 | 0.140 |
Why?
|
| Intercellular Junctions | 1 | 2017 | 9 | 0.130 |
Why?
|
| Fertility Agents, Female | 1 | 2017 | 15 | 0.130 |
Why?
|
| Endometrium | 1 | 2017 | 39 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 136 | 0.130 |
Why?
|
| Fertility | 1 | 2017 | 60 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 346 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2020 | 2662 | 0.120 |
Why?
|
| G-Protein-Coupled Receptor Kinases | 1 | 2016 | 1 | 0.120 |
Why?
|
| Receptors, Oxytocin | 1 | 2016 | 3 | 0.120 |
Why?
|
| Indians, North American | 1 | 2020 | 548 | 0.120 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 514 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 329 | 0.100 |
Why?
|
| Fetal Death | 1 | 2012 | 21 | 0.090 |
Why?
|
| Fetal Growth Retardation | 1 | 2012 | 32 | 0.090 |
Why?
|
| Receptors, Leptin | 1 | 2011 | 6 | 0.090 |
Why?
|
| rho-Associated Kinases | 1 | 2011 | 12 | 0.080 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2011 | 25 | 0.080 |
Why?
|
| KCNQ Potassium Channels | 1 | 2011 | 1 | 0.080 |
Why?
|
| Ovariectomy | 1 | 2010 | 53 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2018 | 881 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2011 | 175 | 0.080 |
Why?
|
| Diabetes, Gestational | 1 | 2011 | 73 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2010 | 124 | 0.080 |
Why?
|
| RNA | 1 | 2010 | 111 | 0.080 |
Why?
|
| Estradiol | 1 | 2010 | 176 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 406 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2008 | 78 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 203 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2021 | 36 | 0.060 |
Why?
|
| Base Sequence | 1 | 2008 | 589 | 0.060 |
Why?
|
| Placenta | 2 | 2016 | 78 | 0.050 |
Why?
|
| Prenatal Diagnosis | 1 | 2021 | 17 | 0.040 |
Why?
|
| Homicide | 1 | 2020 | 7 | 0.040 |
Why?
|
| Maternal Mortality | 1 | 2020 | 10 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2020 | 21 | 0.040 |
Why?
|
| Liability, Legal | 1 | 2020 | 6 | 0.040 |
Why?
|
| Medication Errors | 1 | 2020 | 26 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 74 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2018 | 288 | 0.030 |
Why?
|
| Connexin 43 | 1 | 2017 | 4 | 0.030 |
Why?
|
| Gap Junctions | 1 | 2017 | 5 | 0.030 |
Why?
|
| Decidua | 1 | 2017 | 4 | 0.030 |
Why?
|
| Embryo Implantation | 1 | 2017 | 6 | 0.030 |
Why?
|
| Embryo Transfer | 1 | 2017 | 13 | 0.030 |
Why?
|
| Myocardium | 1 | 2018 | 197 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2018 | 202 | 0.030 |
Why?
|
| Cell Communication | 1 | 2017 | 70 | 0.030 |
Why?
|
| Water | 1 | 2017 | 135 | 0.030 |
Why?
|
| Stillbirth | 1 | 2016 | 15 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 96 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 202 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 247 | 0.030 |
Why?
|
| Pressure | 1 | 2015 | 91 | 0.030 |
Why?
|
| Male | 3 | 2016 | 14127 | 0.030 |
Why?
|
| United States | 1 | 2020 | 2270 | 0.030 |
Why?
|
| Uterine Artery | 1 | 2012 | 1 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 88 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2012 | 125 | 0.020 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2011 | 33 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 58 | 0.020 |
Why?
|
| Anthracenes | 1 | 2011 | 7 | 0.020 |
Why?
|
| Phenylenediamines | 1 | 2011 | 2 | 0.020 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2011 | 9 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2011 | 10 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2011 | 9 | 0.020 |
Why?
|
| Carbamates | 1 | 2011 | 5 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 60 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2011 | 20 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2011 | 119 | 0.020 |
Why?
|
| Heart Rate | 1 | 2012 | 383 | 0.020 |
Why?
|
| Gestational Age | 1 | 2011 | 147 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 253 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 157 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1619 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 1524 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 1502 | 0.010 |
Why?
|